Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137480 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Charlotte Ytterbrink und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospi…. Hauptthemen laut MEDLINE: Alpha-Globulins, Octreotide, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Society, Jubilee Clinic Cancer Foundation.
Abstract (Originalsprache)
Recombinant α1-microglobulin (A1M) is proposed as a protector during 177Lu-octreotate treatment of neuroendocrine tumors, which is currently limited by bone marrow and renal toxicity. Co-administration of 177Lu-octreotate and A1M could result in a more effective treatment by protecting healthy tissue, but the radioprotective action of A1M is not fully understood. The aim of this study was to examine the proteomic response of kidneys and bone marrow early after 177Lu-octreotate and/or A1M administration. Mice were injected with 177Lu-octreotate and/or A1M, while control mice received saline or A1M vehicle solution. Bone marrow, kidney medulla, and kidney cortex were sampled after 24 h or 7 d. The differential protein expression was analyzed with tandem mass spectrometry. The dosimetric estimation was based on 177Lu activity in the kidney. PHLDA3 was the most prominent radiation-responsive protein in kidney tissue. In general, no statistically significant difference in the expression of radiation-related proteins was observed between the irradiated groups. Most canonical pathways were identified in bone marrow from the 177Lu-octreotate+A1M group. Altogether, a tissue-dependent proteomic response followed exposure to 177Lu-octreotate alone or together with A1M. Combining 177Lu-octreotate with A1M did not inhibit the radiation-induced protein expression early after exposure, and late effects should be further studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
- Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
- Section of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Radiation Physics, Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Clinical Sciences Lund, Oncology, Lund University, 221 00 Lund, Sweden.
ORCID-Profile: Toshima Z Parris, Sven-Erik Strand, Magnus Gram, Khalil Helou, Eva Forssell-Aronsson
Förderung
- Swedish Research Council
- Swedish Cancer Society
- Jubilee Clinic Cancer Foundation
- Sahlgrenska University Hospital
- The Swedish state
- Wilhelm and Martina Lundgren Research Foundation
- Assar Gabrielsson Foundation
- Herbert & Karin Jacobsson Foundation
Zitieren
APA
Ytterbrink, C., Shubbar, E., Parris, T. Z., Langen, B., Druid, M., Schüler, E., Strand, S. E., Åkerström, B., Gram, M., Helou, K., & Forssell-Aronsson, E. (2024). Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137480
Vancouver
Ytterbrink C, Shubbar E, Parris TZ, Langen B, Druid M, Schüler E, et al. Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137480
BibTeX
@article{Ytterbrink2024,
author = {Ytterbrink, Charlotte and Shubbar, Emman and Parris, Toshima Z and Langen, Britta and Druid, Malin and Schüler, Emil and Strand, Sven-Erik and Åkerström, Bo and Gram, Magnus and Helou, Khalil and Forssell-Aronsson, Eva},
title = {Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137480}
}
EUVIMED